Charles Rivers Associates’ Andrew Parece and Matthew Majewski discuss how payers view the pricing of rare disease therapies, how context changes perceptions around pricing, and why they began their questioning of payers around the issue of fairness.

Payer Perceptions of Fairness in Pricing Rare Disease Therapies

<p>RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy. </p>

Business

RARECast is a Global Genes podcast hosted by award-winning journalist Daniel Levine. It focuses on the intersection of rare disease with business, science, and policy.

Share Payer Perceptions of Fairness in Pricing Rare Disease Therapies

Sign up to save your podcasts

Payer Perceptions of Fairness in Pricing Rare Disease Therapies

Payer Perceptions of Fairness in Pricing Rare Disease Therapies